首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >DETECTING MEDICATION ERRORS FROM ADVERSE DRUG REACTION MONITORING CENTRE DATABASE – A RETROSPECTIVE ANALYSIS
【24h】

DETECTING MEDICATION ERRORS FROM ADVERSE DRUG REACTION MONITORING CENTRE DATABASE – A RETROSPECTIVE ANALYSIS

机译:从不良药物反应监测中心数据库中检测出药物错误–回顾性分析

获取原文
获取外文期刊封面目录资料

摘要

Introduction: Despite the traditional focus on adverse drug reactions, pharmacovigilance centres have recently been identified as a potentially rich and important source of medication error (ME) data. The aim of this study is to identify ME from adverse drug reaction (ADRs) reports. Materials and methods: A retrospective analysis of ADR reports notified to adverse drug reaction monitoring centre of tertiary care teaching hospital and medical college during January 2014 to December 2016 was done. Those reports which had inappropriate information were excluded. Result: A total of 651 reports met the inclusion criteria and were reviewed, The mean age and weight of patients experienced ADRs due to ME was 32.6 ± 16.1 years and 51.9 ± 17.3 kg respectively, among which 35 men and 39 women. Regarding type of medication errors, most of them were related to monitoring errors (56.2%) followed by prescribing errors (37.5%). Considering categories of ME, 73.4% was into category E which was related to temporary harm to the patient. Majority of ADR reports were mild in nature and produce mild temporary harm to the patients. Conclusion: Explore new role of pharmacovigilance centre to identify medication error which is preventable and indirectly improve quality of health care system and ensuring patient safety.
机译:简介:尽管传统上将重点放在药物不良反应上,但药物警戒中心最近被确定为潜在的丰富且重要的药物错误(ME)数据来源。这项研究的目的是从药物不良反应(ADR)报告中鉴定出ME。材料与方法:对2014年1月至2016年12月通知三级教学医院及医学院附属药品不良反应监测中心的ADR报告进行回顾性分析。那些信息不当的报告被排除在外。结果:共有651份符合纳入标准的报告进行了审查,患有ME的ADR患者的平均年龄和体重分别为32.6±16.1岁和51.9±17.3 kg,其中男35例,女39例。关于用药错误的类型,大多数与监测错误有关(56.2%),其次是处方错误(37.5%)。考虑到ME的类别,有73.4%属于E类,这与对患者的暂时伤害有关。大多数ADR报告本质上都是轻度的,会对患者产生轻度的暂时伤害。结论:探索药物警戒中心的新作用,确定可预防的药物错误,间接改善医疗保健系统的质量并确保患者安全。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号